AmCad BioMed Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24.6	17.76	29.66	47.04	58.51
Short-Term Investments	340.62	339.95	252.61	280.78	312.54
Trading Asset Securities	-	4	5	3.02	-
Cash & Short-Term Investments	365.22	361.71	287.27	330.84	371.05
Cash Growth	0.97%	25.91%	-13.17%	-10.84%	-6.09%
Accounts Receivable	9.34	20.66	11.35	4.51	5.78
Other Receivables	0.02	0.01	-	0.06	0.13
Receivables	9.37	20.66	11.35	4.57	5.91
Inventory	27.34	30.09	25.02	23.33	21.24
Prepaid Expenses	2.04	1.28	2.07	1.02	2.03
Other Current Assets	6.03	4.34	0.18	0.12	0.31
Total Current Assets	410	418.09	325.89	359.88	400.54
Property, Plant & Equipment	75.21	82.92	82.71	79.81	88.23
Long-Term Investments	75.8	125.68	28.06	28.74	34.47
Goodwill	31.18	31.18	31.18	31.18	31.18
Other Intangible Assets	28.77	35.15	42.5	50.54	58.62
Other Long-Term Assets	1.75	1.87	2.3	3.72	2.72
Total Assets	622.7	694.87	512.65	553.86	615.75
Accounts Payable	1.32	2.74	1.95	1.06	1.15
Current Portion of Leases	1.31	5.15	4.4	3.88	4.42
Current Unearned Revenue	0.46	0.51	2.05	2.67	5.45
Other Current Liabilities	15.04	16.75	16.02	19.75	15.11
Total Current Liabilities	18.13	25.14	24.42	27.36	26.13
Long-Term Leases	3.44	5.72	9.99	6.43	10.31
Other Long-Term Liabilities	0.32	0.29	0.29	0.29	0.28
Total Liabilities	21.88	31.16	34.7	34.08	36.72
Common Stock	633.33	633.33	532.56	532.21	532.21
Additional Paid-In Capital	142.17	141.52	8.02	95.74	94.92
Retained Earnings	-253.08	-199.32	-148.74	-192.06	-138.57
Comprehensive Income & Other	-0.99	-6.88	-11.25	-11.32	-5.59
Total Common Equity	521.42	568.65	380.58	424.58	482.98
Minority Interest	79.4	95.07	97.37	95.2	96.06
Shareholders' Equity	600.82	663.72	477.95	519.78	579.03
Total Liabilities & Equity	622.7	694.87	512.65	553.86	615.75
Total Debt	4.75	10.87	14.39	10.31	14.73
Net Cash (Debt)	360.47	350.84	272.88	320.53	356.32
Net Cash Growth	2.75%	28.57%	-14.87%	-10.04%	-8.84%
Net Cash Per Share	5.69	6.08	5.13	6.02	6.70
Filing Date Shares Outstanding	63.33	63.33	53.26	53.22	53.22
Total Common Shares Outstanding	63.33	63.33	53.26	53.22	53.22
Working Capital	391.87	392.94	301.47	332.52	374.41
Book Value Per Share	8.23	8.98	7.15	7.98	9.07
Tangible Book Value	461.48	502.33	306.9	342.87	393.18
Tangible Book Value Per Share	7.29	7.93	5.76	6.44	7.39
Land	52.94	52.94	52.94	52.94	52.94
Buildings	8.14	8.14	8.14	8.14	8.14
Machinery	14.99	15.57	25.15	48.47	47.34
Leasehold Improvements	-	-	-	0.82	0.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.